Bioengineered 'External Liver' tested as bridge to recovery
Disease control
Completed
This early-stage study tested the safety of a temporary, external bioengineered liver device called miroliverELAP. It was used for up to 48 hours in 10 critically ill adults with sudden, severe liver failure. The goal was to see if the device could safely support patients' failin…
Phase: PHASE1 • Sponsor: Miromatrix Medical Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC